Research Article
Chemical Constituents from the Fruits of Forsythia suspensa
and Their Antimicrobial Activity
Ping-Chung Kuo,1 Guo-Feng Chen,1,2 Mei-Lin Yang,2 Ya-Hua Lin,1 and Chi-Chung Peng1
1 Department of Biotechnology, National Formosa University, Yunlin 632, Taiwan
2Department of Chemistry, National Chung-Hsing University, Taichung 402, Taiwan
Correspondence should be addressed to Ping-Chung Kuo; pcckuoo@sunws.nfu.edu.tw
Received 22 December 2013; Revised 6 February 2014; Accepted 9 February 2014; Published 12 March 2014
Academic Editor: JoseÂ´ Carlos Tavares Carvalho
Copyright Â© 2014 Ping-Chung Kuo et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Lignans and phenylethanoid glycosides purified from Forsythia suspensa were reported to display various bioactivities in the
previous literature, including the antimicrobial activity.Therefore, the present research is aimed to purify and identify the chemical
constituents of the methanol extracts of fruits of F. suspensa. The methanol extracts of fruits of F. suspensa were fractionated and
further purified with the assistance of column chromatography to afford totally thirty-four compounds. Among these isolates, 3ğ›½-
acetoxy-20ğ›¼-hydroxyursan-28-oic acid (1) was reported from the natural sources for the first time. Some of the purified principles
were subjected to the antimicrobial activity examinations against Escherichia coli to explore new natural lead compounds.
1. Introduction
Food safety is an important public health issue continuously
attracting researchers from various fields. The use of biop-
reservatives and pathogen antagonists had been completed
as a means of protecting the microbiological safety of fresh
and processed products [1â€“4]. Lignans and phenylethanoid
glycosides are widely distributed among plant bioresources
and those purified from Forsythia suspensa have already been
reported to exhibit antimicrobial bioactivities in the previous
literature [5â€“13]. Although these natural compounds did
not exhibit better inhibition of the bacterial growth, they
were not very toxic while compared with the synthetic
antibiotics. F. suspensa (Oleaceae) is an important original
plant of the crude drug â€œrengyoâ€ (Forsythiae Fructus) which
has been used for anti-inflammatory, diuretic, drainage, and
antimicrobial purposes in Oriental medicine [6, 8]. Previous
phytochemical investigations of Forsythia genus afforded a
series of steroids, triterpenoids, lignans, and phenylethanoid
glycosides [5â€“16]. In our continuous program aimed to the
bioactive principles from natural sources, the fruits of F.
suspensawere selected as the target due to their antimicrobial
potential in our preliminary bioassay (Table 1). In the present
study, we wished to report the structural characterization
of one new triterpene, 3ğ›½-acetoxy-20ğ›¼-hydroxyursan-28-oic
acid (1), alongwith thirty-three known compounds, as well as
their antimicrobial effects against E. coli.We hoped to explore
new lead compounds which could be performed for further
investigation of the new antibiotic agents.
2. Materials and Methods
2.1. General Procedure. Melting point was determined by a
Fisher Scientific melting point measuring apparatus without
corrections. The IR spectrum was obtained, as a KBr disc,
on a Bruker Tensor 27 FT-IR spectrometer. Optical rotation
was measured with an Atago AP-300 automatic polarimeter.
1H- and 13C-NMR, COSY, HMQC, HMBC, and NOESY
spectra were recorded on the Varian Unity 400 and Bruker
AV 500NMR spectrometers, using tetramethylsilane (TMS)
as the internal standard. Standard pulse sequences and
parameters were used for the NMR experiments and all
chemical shifts were reported in parts per million (ppm, ğ›¿).
The low and high-resolution FABmass spectra were obtained
on a JEOL JMS-700 spectrometer operated in the positive-ion
mode. All the chemicals were purchased from Merck KGaA
(Darmstadt, Germany) unless specifically indicated. Column
Hindawi Publishing Corporation
BioMed Research International
Volume 2014, Article ID 304830, 7 pages
http://dx.doi.org/10.1155/2014/304830
2 BioMed Research International
Table 1: The minimum inhibitory concentrations (MICs) of the
crude extract and partial purified fractions of F. suspensa against E.
coli (BCRC-11634).
Sample MIC (mg/mL)
FS (crude extracts) 4.25
FSC (chloroform fraction) 6.25
FSW (water fraction) 12.50
chromatography was performed on silica gels (Kieselgel 60,
70â€“230 mesh, Merck KGaA). Thin layer chromatography
(TLC) was conducted on precoated Kieselgel 60 F 254 plates
(Merck) and the compounds were visualized by UV light or
spraying with 10% (v/v) H
2
SO
4
followed by heating at 110âˆ˜C
for 10min.
2.2. Plant Materials. The fruits of Forsythia suspensa were
purchased from the herbal markets in Yunlin, Taiwan, and
authenticated by Dr. C. S. Kuoh (Department of Bioscience,
National ChengKungUniversity, Tainan, Taiwan). A voucher
specimen (PCKuo 2007001) was deposited in the herbarium
of the Department of Biotechnology, National Formosa
University, Yunlin, Taiwan.
2.3. Extraction and Isolation. The fruits of Forsythia sus-
pensa (6.0 Kg) were powdered and refluxed with methanol
(20 L Ã— 7), and the combined extracts were concentrated
under reduced pressure to give a brown syrup (1.4 Kg). The
crude extract was suspended into water and partitioned with
chloroform, successively to afford chloroform (450 g) and
water soluble fractions (950 g), respectively.
The chloroform soluble extracts were purified by silica
gel column chromatography (SiO
2
CC) eluted with n-hexane
and acetone gradients (100 : 1 to 1 : 1) to afford 8 fractions as
monitored by TLC. Fractions 4, 5, and 8 display significant
spots and therefore were subjected to the further purifica-
tion. Fraction 4 was purified by SiO
2
CC eluted with n-
hexane/ethyl acetate (50 : 1) to yield three subfractions (F4.1âˆ¼
4.3). The subfraction F4.2 displayed significant spots and
was applied to SiO
2
CC, eluted with n-hexane and acetone
gradients (100 : 1 to 1 : 1), to afford ğ›½-amyrin acetate (2)
(10mg) and taraxasterol acetate (3) (6mg). The subfraction
F4.3 was purified with SiO
2
CC eluted with n-hexane and
acetone gradients (300 : 1 to 1 : 1) to yield three minor frac-
tions (F4.3.1âˆ¼4.3.3). The minor fraction F4.3.1 was further
applied to SiO
2
CCwith benzene : ethyl acetate (50 : 1) solvent
system to afford 3ğ›½-acetyl-20,25-epoxy-dammarane-24ğ›¼-ol
(4) (25mg). F4.3.2 was repeatedly subjected to SiO
2
CC
and preparative TLC (pTLC) (eluted with benzene : acetone,
20 : 1) to yield 3ğ›½-acetoxy-20ğ›¼-hydroxyursan-28-oic acid (1)
(10mg). F4.3.3 was recrystallized with acetone to produce
acetyl oleanolic acid (5) (20mg). Fraction 5 was purified by
SiO
2
CC eluted with n-hexane/ethyl acetate (50 : 1) to yield
ten subfractions (F5.1âˆ¼5.10). Subfractions F5.5, 5.6, 5.8, and
5.10 were major fractions and displayed significant spots by
TLC monitoring. F5.5 was further isolated by SiO
2
CC with
a mixed eluent of benzene and acetone (200 : 1) to afford
3ğ›½-acetyl-20,25-epoxy-dammarane-24ğ›¼-ol (4) (20mg). F5.6
was also subjected to SiO
2
CC with a mixed eluent of
benzene and acetone (200 : 1) and further recrystallization
of the minor fractions with chloroform/methanol to yield
betulinic acid (6) (30mg) and labda-8(17),13E-dien-15,18-
dioic acid 15-methyl ester (7) (5mg), respectively. F5.8 was
recrystallized with chloroform/methanol to produce mixture
of ğ›½-sitosterol (8) and stigmasterol (9) (630mg). F5.10 was
repeatedly subjected to SiO
2
CC and pTLC (eluted with
benzene : acetone, 20 : 1) to yield ğœ“-taraxasterol (10) (8mg).
Fraction 8 was subjected to SiO
2
CC eluted with
chloroform/methanol gradients (50 : 1 to 1 : 1) and monitored
by TLC to afford five subfractions (F8.1âˆ¼8.5). Subfraction F8.1
was further recrystallized with chloroform/methanol to yield
betulinic acid (6) (2mg). F8.2 was repeatedly subjected to
SiO
2
CC and pTLC (eluted with chloroform :methanol,
50 : 1) to afford ğœ“-taraxasterol (10) (2mg) and 3ğ›½-
hydroxyanticopalic acid (11) (12mg), respectively. The
subfraction F8.3 was purified with SiO
2
CC eluted with
chloroform and methanol gradients (50 : 1 to 1 : 1) to
yield three minor fractions (F8.3.1âˆ¼8.3.3). The minor
fraction F8.3.2 was further applied to pTLC eluted
with benzene/acetone (10 : 1) to yield agatholic acid (12)
(9mg). F8.3.3 was repeatedly subjected to SiO
2
CC (eluted
with chloroform/acetone, 50 : 1) and pTLC (eluted with
benzene/acetone, 30 : 1) to yield 3,4-dimethoxybenzoic
acid (13) (6mg). Subfraction F8.4 was applied to SiO
2
CC
eluted with chloroform and methanol gradients (50 : 1 to
1 : 1) to yield four minor fractions (F8.4.1âˆ¼8.4.4). The minor
fractions F8.4.2 and 8.4.3 were major fractions and displayed
significant spots by TLC monitoring. F8.4.2 was further
repeatedly subjected to SiO
2
CC and pTLC (eluted with
n-hexane/acetone, 1 : 1) to yield vanillic acid (14) (12mg) and
syringic acid (15) (3mg). F8.4.3 was further recrystallized
with chloroform/methanol to yield phillyrin (16) (30mg).
Subfraction F8.5 was purified by SiO
2
CC eluted with
chloroform and methanol gradients (50 : 1 to 1 : 1) to yield
three minor fractions (F8.5.1âˆ¼8.5.3). The minor fraction
F8.5.1 was further repeatedly subjected to SiO
2
CC and
pTLC (eluted with chloroform/ethyl acetate, 10 : 1) to afford
p-hydroxyphenylacetic acid (17) (10mg). F8.5.2 was isolated
by pTLC eluted with chloroform/acetone (4 : 1) to produce
p-hydroxybenzoic acid (18) (15mg). F8.5.3 was further
recrystallized with acetone to yield benzoic acid (19) (16mg).
The water extracts were applied to a reversed-phase
Diaion HP-20 column eluted with water and methanol
gradients to afford six fractions as monitored by C-18 TLC;
however, no constituents were identified from fractions 1â€“
3. Fraction 4 (wF4) was subjected to SiO
2
CC eluted with
chloroform/methanol gradients (100 : 1 to 1 : 1) and moni-
tored by TLC to afford five subfractions (wF4.1âˆ¼4.5). The
subfraction wF4.1 was purified with SiO
2
CC eluted with
chloroform and acetone gradients (100 : 1 to 1 : 1) to yield p-
hydroxyphenylacetic acid methyl ester (20) (5mg). Subfrac-
tion wF4.2 was applied to SiO
2
CC eluted with chloroform
and acetone gradients (200 : 1 to 1 : 1) to yield four minor
fractions (wF4.2.1âˆ¼wF4.2.4). The minor fraction wF4.2.1 was
further recrystallized with chloroform/methanol to afford
p-tyrosol (21) (10mg). The minor fractions wF4.2.2 and
wF4.2.3 were further repeatedly subjected to SiO
2
CC and
BioMed Research International 3
pTLC (eluted with chloroform/methanol, 30 : 1) to afford p-
hydroxybenzoic acid (18) (5mg) and p-hydroxyphenylacetic
acid (17) (4mg), respectively.Theminor fractionwF4.2.4 was
subjected to SiO
2
CC and further purified by pTLC (eluted
with chloroform/methanol, 20 : 1) to yield hydroxytyrosol
(22) (3mg). Subfraction wF4.4 was subjected to SiO
2
CC
eluted with chloroform and acetone gradients (100 : 1 to
1 : 1) to yield five minor fractions (wF4.4.1âˆ¼wF4.4.5). The
minor fractions wF4.4.2, wF4.4.4, and wF4.4.5 displayed
significant spots and were applied to SiO
2
CC, eluted with
chloroform/methanol (10 : 1) to afford 2-furancarboxylic acid
(23) (15mg), salidroside (24) (18mg), and (6S,9R)-roseoside
(25) (10mg), respectively. Subfraction wF4.5 was repeatedly
subjected to SiO
2
CC (eluted with chloroform/methanol,
10 : 1) and further recrystallization of theminor fractions with
chloroform/methanol to result in forsythoside D (26) (8mg),
methyl-ğ›¼-D-glucopyranoside (27) (10mg), and adoxosidic
acid (28) (15mg), respectively.
Fraction 5 (wF5) was subjected to SiO
2
CC eluted
with chloroform/methanol gradients (200 : 1 to 1 : 1) and
monitored by TLC to afford five subfractions (wF5.1âˆ¼5.5).
Subfractions wF5.1, wF5.3, and wF5.4 displayed significant
spots and therefore were subjected to the further purifi-
cation. Subfraction wF5.1 was repeatedly subjected to SiO
2
CC (eluted with chloroform/acetone, 300 : 1 to 1 : 1) and
further recrystallized with chloroform/methanol to result
in p-hydroxyphenylacetic acid methyl ester (20) (3mg).
Subfraction wF5.3 was applied to SiO
2
CC (eluted with
chloroform/acetone, 300 : 1 to 1 : 1) and further recrystallized
with chloroform/methanol to yield p-hydroxyphenylacetic
acid (17) (5mg) and protocatechualdehyde (29) (5mg).
SubfractionwF5.4was repeatedly purified by SiO
2
CC (eluted
with chloroform/acetone, 200 : 1 to 1 : 1) and further recrys-
tallization of the minor fractions with chloroform/methanol
to yield esculetin (30) (3mg) and caffeic acid (31) (12mg),
respectively. Fraction 6 (wF6) was isolated by SiO
2
CC
eluted with chloroform/methanol gradients (100 : 1 to 1 : 1)
and monitored by TLC to result in five subfractions (wF6.1âˆ¼
6.5). Only subfractions wF6.2 andwF6.3 displayed significant
spots and therefore were subjected to the further purification.
SubfractionwF6.2was repeatedly purified by SiO
2
CC (eluted
with chloroform/acetone, 200 : 1 to 1 : 1) and further recrys-
tallization of the minor fractions with acetone to yield trans-
coumaric acid (32) (5mg) and trans-ferulic acid (33) (5mg).
Subfraction wF6.3 was further recrystallized with acetone to
result in quercetin (34) (45mg).
2.3.1. Spectral Data of 1. White powder (CHCl
3
), mp 238â€“
245âˆ˜C; [ğ›¼]25
ğ·
âˆ’118.0 (c 0.09, CHCl
3
); IR (Neat) ]max: 3442,
2948, 1760, 1727, 1444, 1375, 1250 cmâˆ’1; 1H NMR (CDCl
3
,
400MHz) ğ›¿ 0.83 (15H, m, CH
3
-23, 24, 25, 27, 29), 0.94 (3H, s,
CH
3
-26), 1.35 (3H, s, CH
3
-30), 2.05 (3H, s, CH
3
-32), 2.10 (1H,
m, H-15), 2.60 (2H, m, H-16), 4.48 (1H, dd, J = 10.4, 5.6Hz,
H-3ğ›¼); 13C NMR (CDCl
3
, 125MHz) ğ›¿ 15.5 (C-26), 16.2 (C-
23, 24, 25), 16.5 (C-27), 18.1 (C-6), 21.3 (C-32), 21.4 (C-11),
23.7 (C-2), 25.0 (C-12), 25.4 (C-30), 26.8 (C-22), 28.0 (C-29),
29.2 (C-16), 31.2 (C-15, 21), 35.1 (C-7), 37.1 (C-10), 37.9 (C-4),
38.7 (C-1), 40.4 (C-8), 43.2 (C-14, 18), 49.4 (C-13), 50.2 (C-17),
50.5 (C-9), 55.9 (C-5), 80.9 (C-3), 90.1 (C-20), 171.0 (C-
31), 176.8 (C-28); FAB-MS m/z (rel. int.) 517 ([M+H]+, 100);
HR-FAB-MS m/z 517.3896 [M+H]+ (calcd for C
32
H
53
O
5
,
517.3893).
2.4. Antimicrobial Activity
2.4.1. Microorganisms. The antimicrobial activity was evalu-
ated against Escherichia coli (BCRC-11634). The strains were
kept at âˆ’70âˆ˜C in Luria-Bertani agar (LBA), activated by
transferring into nutritive agar and incubating at 37 Â± 1.0âˆ˜C
for 18 h.The bacterial suspension of each strain was prepared
in a sterile tube with glass pearls and turbidity adjusted with
distillatedwater, according toMcFarland scale number 1 tube,
which corresponds to approximately 3 Ã— 108 CFU/mL [13].
2.4.2. Determination of the In Vitro Antimicrobial Activity.
Theantimicrobial activities against E. coli of different concen-
trations of tested samples were determined by the microtiter
plate method described by the United States Pharmacopeia
[17]. A twofold microdilution broth method was used to
determinate the minimum inhibitory concentrations (MIC)
value for each test substance [18â€“21]. Each well contained
106 CFU/mL of test bacteria and LBmedium (100 ğœ‡L). 100 ğœ‡L
of MeOH solutions of tested samples (5mg/mL for pure
compounds and 20mg/mL for the fractions) was added to
wells of the first row. Dilutions were used to dispense 100 ğœ‡L
into the other sterile 96 wells of an ELISA plate using a mul-
tichannel micropipette, resulting in eight concentrations to
be tested for each compound. A negative control containing
inoculated growthmediumandmethanolwas prepared. Each
experiment was performed in triplicate.
2.4.3. Minimum Inhibitory Concentration (MIC) Determina-
tion. The MIC value is a measure to define the antibacterial
activity of a compound and is defined as the lowest concen-
tration of drug that inhibits visible growth. The amount of
growth in the wells containing test samples was compared
with the amount of growth in the control wells when
determining the growth end points. When a single skipped
well occurred, the highest MIC was read.
3. Results and Discussion
3.1. Isolation and Characterization of Compounds. Dried
and powdered fruits of F. suspensa were extracted with
methanol, and the combined extracts were concentrated
under reduced pressure to give deep brown syrup. The
crude extract was suspended into water and partitioned
with chloroform to afford chloroform and water solu-
ble fractions, respectively. Purification of the chloroform
fraction of the methanol extracts of fruits of F. suspensa
by a combination of chromatographic techniques yielded
one new triterpene, 3ğ›½-acetoxy-20ğ›¼-hydroxyursan-28-oic
acid (1) (Figure 1), ğ›½-amyrin acetate (2) [22], taraxasterol
acetate (3) [23], 3ğ›½-acetyl-20,25-epoxy-dammarane-24ğ›¼-ol
(4) [24], acetyl oleanolic acid (5) [25], betulinic acid (6)
[26], labda-8(17),13E-dien-15,18-dioic acid 15-methyl ester
4 BioMed Research International
H
H
H
O
23 24
25 26
27
28
1
2
3
4
5
6 7
8
9
10
11
12
13
14
15
16
17
18
19 2029
30
21
22
HO
O
31
32
1
CO2H
Figure 1: Chemical structure, significant HMBC (â†’ ) and NOESY
(â†”) correlations of compound 1.
(7) [27], mixture of ğ›½-sitosterol (8) and stigmasterol (9)
[28], ğœ“-taraxasterol (10) [29], 3ğ›½-hydroxyanticopalic acid
(11) [30], agatholic acid (12) [31], 3,4-dimethoxybenzoic
acid (13) [32], vanillic acid (14) [33], syringic acid (15)
[33], phillyrin (16) [15], p-hydroxyphenylacetic acid (17)
[34], p-hydroxybenzoic acid (18) [33], and benzoic acid
(19) [35], respectively. The water fraction was subjected to
the reversed-phase Diaion HP-20 column chromatography
and successive isolation to afford p-hydroxyphenylacetic acid
(17), p-hydroxybenzoic acid (18), p-hydroxyphenylacetic acid
methyl ester (20) [36], p-tyrosol (21) [37], hydroxytyrosol
(22) [38], 2-furancarboxylic acid (23) [39], salidroside (24)
[40], (6S,9R)-roseoside (25) [41], forsythoside D (26) [8],
methyl-ğ›¼-D-glucopyranoside (27) [42], adoxosidic acid (28)
[43], protocatechualdehyde (29) [44], esculetin (30) [45],
caffeic acid (31) [46], trans-coumaric acid (32) [47], trans-
ferulic acid (33) [48], and quercetin (34) [49], respectively.
The chemical structures of known compounds 2â€“34 were
identified by comparison of their physical and spectroscopic
data with those reported in the literature. Among the isolates,
compounds 2, 4, 6, 8, 14, 16, 17, 24, 26, 28, 31, and 34 had
been identified from the titled plant. Other compounds were
reported from F. suspensa for the first time. Compound 1 was
a new compound and its structure was established by the
spectral analysis.
3.2. Structural Elucidation of Compound 1. Thepurifiedwhite
powder 1 was visualized by spraying with 1% (w/v) Ce(SO
4
)
2
in 10% (v/v) aqueous H
2
SO
4
followed by heating at 120âˆ˜C
and displayed purplish black spots on TLC plate. It also
displayed positive responses against the Lieberman-Burchard
test. These results suggested compound 1 to be a triterpenoid
[50].Themolecular formula of 1was established as C
32
H
52
O
5
by the pseudomolecular [M+H]+ ion peak atm/z 517.3896 in
HR-FAB-MS analysis and was further supported by its 13C-
NMR spectrum which showed signals for all the 32 carbons
of the molecule including one set of acetyl group (ğ›¿C 171.0,
Table 2: The minimum inhibitory concentrations (MICs) of the
purified samples from F. suspensa against E. coli (BCRC-11634).
Compound MIC (mg/mL)
1 4.55
2 5.00
6 1.20
10 1.20
11 3.42
12 2.62
16 3.94
21.3), one carboxylic acid group (ğ›¿C 176.8), one oxygenated
quaternary carbon (ğ›¿C 90.1), and one acetoxygenated carbon
(ğ›¿C 80.9), respectively. In the
1H-NMR spectrum of 1, there
were proton signals for sevenmethyl groups at ğ›¿ 0.83 (15H,m,
and CH
3
-23, -24, -25, -27, and -29), 0.94 (3H, s, and CH
3
-26),
and 1.35 (3H, s, and CH
3
-30), and one acetyl methyl group at
ğ›¿ 2.05 (3H, s, and CH
3
-32), respectively. The spectroscopic
data indicated compound 1 to possess oleanane type basic
skeleton. In the downfield region, one oxygenated proton at ğ›¿
4.48 (1H, dd, J = 10.4, 5.6Hz, H-3ğ›¼) was located at C-3 which
was further established by the NOESY correlations between
CH
3
-23 and H-3. The 2J, 3J-HMBC correlations from ğ›¿ 4.48
(H-3) to ğ›¿C 21.3 (C-32) and 171.0 (C-31) also evidenced the
presence of acetoxy group at C-3. The substitution of tertiary
alcohol at C-20 was also determined with the HMBC analysis
of correlations from CH
3
-30 to C-21 (ğ›¿C 31.2) and C-20 (ğ›¿C
90.1). The 2J, 3J-HMBC correlation peak between ğ›¿ 2.60 (m,
H-16) and ğ›¿C 176.8 (C-28) supported the carboxylic acid
group to be attached at C-17.The complete assignments of 1H
and 13C NMR signals of 1 were furnished from the NOESY
andHMBC spectra.Therefore the chemical structure of 1was
established as 3ğ›½-acetoxy-20ğ›¼-hydroxyursan-28-oic acid and
shown in Figure 1.
3.3. The Antimicrobial Effects of Isolated Compounds against
Escherichia coli. The crude extracts, partially purified frac-
tions, and some of the purified principles (Figure 2) were
subjected to the examinations for the inhibitory effects
against E. coli [17â€“21]. The MIC data of the fractions were
presented in Table 1. The MIC value of crude extracts (FS)
was 4.25mg/mL and demonstrated inhibition of the bacte-
rial growth. Comparatively, the chloroform fraction (FSC)
displayed more significant inhibitory effects against E. coli
(BCRC-11634) than the water fraction (FSW) with MIC
values of 6.25 and 12.50mg/mL, respectively. When studying
the influence of the concentration of compounds on the
antimicrobial activities against E. coli, twofold microdilution
broth method was used for the purified principles from the
chloroform fraction (FSC), including triterpenoids 1,2,6, and
10; diterpenoids 11 and 12; and lignan 16. It was observed that
as the concentration increased, the inhibition of the bacterial
growth was also increased. All of the tested samples demon-
strated the inhibitory effects in a concentration-dependent
manner. The MIC data of the examined compounds were
presented in Table 2. The MIC values were in the range
BioMed Research International 5
H
H
H
AcO
HO
1
CO2H
H
H
H
AcO
2
H
H
H
H
HO
6
CO2H
H
H
H
HO
10
H
HO
11
CO2H
H
12
CO2H
CH2OH
OHO
HO
OH
HO
O
O
O
HH
16
OCH3
OCH3
H3CO
Figure 2: Structures of the isolated compounds subjected to the antimicrobial assay.
between 1.20 and 5.00mg/mL against E. coli (BCRC-11634).
Among the tested compounds, triterpenoids betulinic acid
(6) and ğœ“-taraxasterol (10) exhibited the most significant
inhibition against E. coli with MIC values of 1.20mg/mL.
These principles should be responsible for the bioactivity of
the chloroform fraction (FSC). The results exhibited that the
triterpenoids from the methanol extracts of fruits of F. sus-
pensa possessed antibacterial activities against the common
bacteria. It also provided evidence for the traditional uses of
the fruits of F. suspensa as herbal medicines in the treatment
of bacterial diseases. Although these purified compounds did
not display better inhibition of the bacterial growth compared
with the reported synthetic antibiotics, the extracts and
principles from the natural sources usually possessed lower
toxicity. Further structural modification could be performed
to improve the activity and maintain the safety of these
compounds. Therefore, it would be potentially useful in
developing new antimicrobial therapeutic agents.
6 BioMed Research International
Conflict of Interests
The authors declare that there is no conflict of interests
regarding the publication of this paper.
Acknowledgment
The authors are grateful to the National Science Council,
Taiwan, for the financial support of this research.
References
[1] T. Abuladze, M. Li, M. Y. Menetrez, T. Dean, A. Senecal, and
A. Sulakvelidze, â€œBacteriophages reduce experimental contam-
ination of hard surfaces, tomato, spinach, broccoli, and ground
beef by Escherichia coli O157:H7,â€ Applied and Environmental
Microbiology, vol. 74, no. 20, pp. 6230â€“6238, 2008.
[2] A. Allende, B. MartÂ´Ä±nez, V. Selma, M. I. Gil, J. E. SuaÂ´rez, and A.
RodrÂ´Ä±guez, â€œGrowth and bacteriocin production by lactic acid
bacteria in vegetable broth and their effectiveness at reducing
Listeria monocytogenes in vitro and in fresh-cut lettuce,â€ Food
Microbiology, vol. 24, no. 7-8, pp. 759â€“766, 2007.
[3] A. L. Brown, J. C. Brooks, E. Karunasena, A. Echeverry, A.
Laury, and M. M. Brashears, â€œInhibition of Escherichia coli
O157:H7 and Clostridium sporogenesin spinach packaged in
modified atmospheres after treatment combined with chlorine
and lactic acid bacteria,â€ Journal of Food Science, vol. 76, no. 6,
pp. M427â€“M432, 2011.
[4] B. Leverentz, W. S. Conway, W. Janisiewicz, M. Abadias, C.
P. Kurtzman, and M. J. Camp, â€œBiocontrol of the food-borne
pathogens Listeria monocytogenes and Salmonella enterica
serovar poona on fresh-cut apples with naturally occurring
bacterial and yeast antagonists,â€ Applied and Environmental
Microbiology, vol. 72, no. 2, pp. 1135â€“1140, 2006.
[5] C. L. Yui, â€œA study of the bacteriostatic principle isolated from
Forsythia suspensa Vahl. (Lien-chiao),â€ Yaoxue Xuebao, vol. 8,
no. 6, pp. 241â€“244, 1960.
[6] K. Endo, K. Takahashi, T. Abe, and H. Hikino, â€œStructure of
forsythoside A, an antibacterial principle of Forsythia suspensa
leaves,â€ Heterocycles, vol. 16, no. 8, pp. 1311â€“1314, 1981.
[7] S. Nishibe, K. Okabe, and H. Tsukamoto, â€œStudies on the
Chinese crude drug â€œForsythiae fructusâ€. VI: the structure and
antibacterial activity of suspensaside isolated from Forsythia
suspensa,â€ Chemical and Pharmaceutical Bulletin, vol. 30, no. 12,
pp. 4548â€“4553, 1982.
[8] K. Endo and H. Hikino, â€œStructures of forsythoside C and D,
antibacterial principles of Forsythia suspensa fruits,â€ Heterocy-
cles, vol. 19, no. 11, pp. 2033â€“2036, 1982.
[9] S. Kitagawa, S. Nishibe, and H. Baba, â€œStudies on the Chinese
crude drug â€œForsythiae fructusâ€. VIII: on isolation of phenyl-
propanoid glycosides from fruits of Forsythia koreana and their
antibacterial activity,â€ Yakugaku Zasshi, vol. 107, no. 4, pp. 274â€“
278, 1987.
[10] S. Nishibe, S. Kitagawa, S. Hisada et al., â€œPhenolic compounds
from Forsythiae fructus and their biological activities,â€ Journal
of Pharmacobio-Dynamics, vol. 10, no. 3, s-48, 1987.
[11] H. X. Kuang, N. Zhang, and Z. B. Lu, â€œAntibacterial con-
stituents of the unripe fruit ofForsythia suspensa (Thunb.)Vahl,â€
Zhongyao Tongbao, vol. 13, no. 7, pp. 32â€“63, 1988.
[12] H. Qu, Y. Zhang, Y. Wang, B. Li, and W. Sun, â€œAntioxidant
and antibacterial activity of two compounds (forsythiaside
and forsythin) isolated from Forsythia suspensa,â€ Journal of
Pharmacy and Pharmacology, vol. 60, no. 2, pp. 261â€“266, 2008.
[13] H. Qu, Y. Zhang, X. Chai, and W. Sun, â€œIsoforsythiaside, an
antioxidant and antibacterial phenylethanoid glycoside isolated
from Forsythia suspensa,â€ Bioorganic Chemistry, vol. 40, no. 1,
pp. 87â€“91, 2012.
[14] S. Kitagawa, S. Nishibe, R. Benecke, and H. Thieme, â€œPhenolic
compounds from Forsythia leaves. II,â€ Chemical & Pharmaceu-
tical Bulletin, vol. 36, no. 9, pp. 3667â€“3670, 1988.
[15] M. M. A. Rahman, P. M. Dewick, D. E. Jackson, and J. A. Lucas,
â€œLignans of Forsythia intermedia,â€ Phytochemistry, vol. 29, no. 6,
pp. 1971â€“1980, 1990.
[16] A. S. S. Rouf, Y. Ozaki, M. A. Rashid, and J. Rui, â€œDammarane
derivatives from the dried fruits of Forsythia suspensa,â€ Phyto-
chemistry, vol. 56, no. 8, pp. 815â€“818, 2001.
[17] The United States Pharmacopeia, USP29-NF24, 2006.
[18] S. Burt, â€œEssential oils: their antibacterial properties and poten-
tial applications in foodsâ€”a review,â€ International Journal of
Food Microbiology, vol. 94, no. 3, pp. 223â€“253, 2004.
[19] M. Friedman, P. R. Henika, and R. E. Mandrell, â€œBactericidal
activities of plant essential oils and some of their isolated
constituents against Campylobacter jejuni, Escherichia coli, Lis-
teria monocytogenes, and Salmonella enterica,â€ Journal of Food
Protection, vol. 65, no. 10, pp. 1545â€“1560, 2002.
[20] L. S. M. Ooi, Y. Li, S. L. Kam, H. Wang, E. Y. L. Wong, and V.
E. C. Ooi, â€œAntimicrobial activities of Cinnamon oil and cin-
namaldehyde from the Chinese medicinal herb Cinnamomum
cassiaBlume,â€American Journal of ChineseMedicine, vol. 34, no.
3, pp. 511â€“522, 2006.
[21] B. Shan, Y. Z. Cai, J. D. Brooks, and H. Corke, â€œThe in
vitro antibacterial activity of dietary spice and medicinal herb
extracts,â€ International Journal of FoodMicrobiology, vol. 117, no.
1, pp. 112â€“119, 2007.
[22] S. Matsunaga, R. Tanaka, and M. Akagi, â€œTriterpenoids from
Euphorbia maculata,â€ Phytochemistry, vol. 27, no. 2, pp. 535â€“537,
1988.
[23] K. K. Bhutani, D. K. Gupta, and R. S. Kapil, â€œOccurrence of D/E
trans stereochemistry isomeric to ursane (cis) series in a new
pentacyclic triterpene from Calotropis procera,â€ Tetrahedron
Letters, vol. 33, no. 49, pp. 7593â€“7596, 1992.
[24] H. Jing, J. S. Lee,W.Cao,C. F. Fang, andP. Lu, â€œDetermination of
forsythoside A from Forsythia suspensa byHPLC,â€Xibei Yaoxue
Zazhi, vol. 18, no. 4, pp. 156â€“157, 2003.
[25] K. Umehara, R. Takagi, M. Kuroyanagi, A. Ueno, T. Taki, and
Y. J. Chen, â€œStudies on differentiation-inducing activities of
triterpenes,â€ Chemical and Pharmaceutical Bulletin, vol. 40, no.
2, pp. 401â€“405, 1992.
[26] A. Nick, A. D. Wright, T. Rali, and O. Sticher, â€œAntibacte-
rial triterpenoids from Dillenia papuana and their structure-
activity relationships,â€ Phytochemistry, vol. 40, no. 6, pp. 1691â€“
1695, 1995.
[27] C. Zdero, F. Bohlmann, and H. M. Niemeyer, â€œFriedolabdanes
and other constituents from chilean Haplopappus species,â€
Phytochemistry, vol. 30, no. 11, pp. 3669â€“3677, 1991.
[28] Y. H. Kuo and Y. C. Li, â€œConstituents of the Bark of Ficus
microcarpa L.f.,â€ Journal of the Chinese Chemical Society, vol. 44,
no. 3, pp. 321â€“325, 1997.
[29] H. Y. Ding, â€œPhytochemical and pharmacological studies on
Chinese changzhu,â€ Journal of the Chinese Chemical Society, vol.
47, no. 3, pp. 561â€“566, 2000.
BioMed Research International 7
[30] S. Braun and H. Breitenbach, â€œStrukturaufklaÂ¨rung einer neuen
diterpensaÂ¨ure aus Metasequoia glyptostroboides mit hilfe der
13C-NMR-spektroskopie,â€ Tetrahedron, vol. 33, no. 1, pp. 145â€“
150, 1977.
[31] J. de Paiva Campello and S. F. Fonseca, â€œDiterpenes from
Araucaria angustifolia,â€Phytochemistry, vol. 14, no. 10, pp. 2299â€“
2300, 1975.
[32] M. Trincado, H. GruÂ¨tzmacher, F. Vizza, and C. Bianchini,
â€œDomino rhodium/palladium-catalyzed dehydrogenation reac-
tions of alcohols to acids by hydrogen transfer to inactivated
alkenes,â€ Chemistry, vol. 16, no. 9, pp. 2751â€“2757, 2010.
[33] C. Y. Chen, F. R. Chang, C. M. Teng, and Y. C. Wu, â€œCheri-
tamine, a new N-fatty acyl tryptamine and other constituents
from the stems of Annona cherimola,â€ Journal of the Chinese
Chemical Society, vol. 46, no. 1, pp. 77â€“86, 1999.
[34] K. Zhang, J. E. T. Corrie, V. R. N. Munasinghe, and P.
Wan, â€œMechanism of photosolvolytic rearrangement of p-
hydroxyphenacyl esters: evidence for excited-state intramolec-
ular proton transfer as the primary photochemical step,â€ Journal
of the AmericanChemical Society, vol. 121, no. 24, pp. 5625â€“5632,
1999.
[35] P. Laurent, B. Lebrun, J. C. Braekman, D. Daloze, and J. M.
Pasteels, â€œBiosynthetic studies on adaline and adalinine, two
alkaloids from ladybird beetles (Coleoptera: Coccinellidae),â€
Tetrahedron, vol. 57, no. 16, pp. 3403â€“3412, 2001.
[36] D. S. Bose and A. V. Narsaiah, â€œAn efficient asymmetric
synthesis of (S)-atenolol: using hydrolytic kinetic resolution,â€
Bioorganic and Medicinal Chemistry, vol. 13, no. 3, pp. 627â€“630,
2005.
[37] Y. Takaya, T. Furukawa, S. Miura et al., â€œAntioxidant con-
stituents in distillation residue of Awamori spirits,â€ Journal of
Agricultural and Food Chemistry, vol. 55, no. 1, pp. 75â€“79, 2007.
[38] L. PouyseÂ´gu, T. Sylla, T. Garnier et al., â€œHypervalent iodine-
mediated oxygenative phenol dearomatization reactions,â€
Tetrahedron, vol. 66, no. 31, pp. 5908â€“5917, 2010.
[39] M. N. Preobrazhenskaya, I. I. Rozhkov, E. I. Lazhko, L. N.
Yudina, and A. M. Korolev, â€œReaction of vanilmandelic acid
and 4-Hydroxybenzyl alcohol derivatives with L-ascorbic acid,â€
Tetrahedron, vol. 53, no. 20, pp. 6971â€“6976, 1997.
[40] H. Kuwajima, Y. Takai, K. Takaishi, and K. Inoue, â€œSynthesis
of 13C-labeled possible intermediates in the biosynthesis of
phenylethanoid derivatives, cornoside and rengyosides,â€Chem-
ical and Pharmaceutical Bulletin, vol. 46, no. 4, pp. 581â€“586,
1998.
[41] Y. Yamano and M. Ito, â€œSynthesis of optically active vomifoliol
and roseoside stereoisomers,â€ Chemical and Pharmaceutical
Bulletin, vol. 53, no. 5, pp. 541â€“546, 2005.
[42] L. Albertin, M. Stenzel, C. Barner-Kowollik, L. J. R. Foster, and
T. P. Davis, â€œWell-defined glycopolymers from RAFT polymer-
ization: poly(methyl 6-O-methacryloyl-ğ›¼-D-glucoside) and its
block copolymer with 2-hydroxyethyl methacrylate,â€ Macro-
molecules, vol. 37, no. 20, pp. 7530â€“7537, 2004.
[43] S. Suciati, L. K. Lambert, B. P. Ross, M. A. Deseo, and M. J.
Garson, â€œPhytochemical study of Fagraea spp. Uncovers a new
terpene alkaloid with anti-inflammatory properties,â€Australian
Journal of Chemistry, vol. 64, no. 4, pp. 489â€“494, 2011.
[44] H. Chiji, S. Tanaka, and M. Izawa, â€œPhenolic germination
inhibitors in the seed balls of red beet (Beta vulgaris L. var.
rubra),â€ Agricultural and Biological Chemistry, vol. 44, no. 1, pp.
205â€“207, 1980.
[45] Y. Masamoto, H. Ando, Y. Murata, Y. Shimoishi, M. Tada,
and K. Takahata, â€œMushroom tyrosinase inhibitory activity
of esculetin isolated from seeds of Euphorbia lathyris L.,â€
Bioscience, Biotechnology and Biochemistry, vol. 67, no. 3, pp.
631â€“634, 2003.
[46] V. D. S. Bolzani, L. M. V. Trevisan, and M. C. M. Young,
â€œCaffeic acid esters and triterpenes of Alibertia macrophylla,â€
Phytochemistry, vol. 30, no. 6, pp. 2089â€“2091, 1991.
[47] Y. M. Chiang, H. K. Liu, J. M. Lo et al., â€œCytotoxic constituents
of the leaves of Calocedrus formosana,â€ Journal of the Chinese
Chemical Society, vol. 50, no. 1, pp. 161â€“166, 2003.
[48] S. Prachayasittikul, S. Suphapong, A. Worachartcheewan, R.
Lawung, S. Ruchirawat, and V. Prachayasittikul, â€œBioactive
metabolites from Spilanthes acmella Murr,â€ Molecules, vol. 14,
no. 2, pp. 850â€“867, 2009.
[49] Y. Hua and H. Q. Wang, â€œChemical components of Anaphalis
sinica hance,â€ Journal of the Chinese Chemical Society, vol. 51,
no. 2, pp. 409â€“415, 2004.
[50] A. Srivastava andY.N. Shukla, â€œAryl esters and a coumarin from
Aygyreia speciosa,â€ Indian Journal of Chemistry B, vol. 37, no. 2,
pp. 192â€“194, 1998.
Submit your manuscripts at
http://www.hindawi.com
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Anatomy 
Research International
Peptides
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation 
http://www.hindawi.com
 International Journal of
Volume 2014
Zoology
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Molecular Biology 
International 
Genomics
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Bioinformatics
Advances in
Marine Biology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Signal Transduction
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Evolutionary Biology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Biochemistry 
Research International
Archaea
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Genetics 
Research International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Advances in
Virolog y
Hindawi Publishing Corporation
http://www.hindawi.com
Nucleic Acids
Journal of
Volume 2014
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Enzyme 
Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
International Journal of
Microbiology
